Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab

International Journal of Rheumatic Diseases

Volumn 14, Issue 1, 2011, Pages 31-36

  Hayata, Koichiro ^a   Kanbe, Katsuaki ^a   Chiba, Junji ^a   Nakamura, Atsushi ^a   Inoue, Yasuo ^a   Hobo, Kaori ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Infliximab; Rheumatoid arthritis; Surgery

Indexed keywords

C REACTIVE PROTEIN; CENTCORE; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; PREDNISOLONE SODIUM SUCCINATE; STROMELYSIN; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; AGGLUTINATION TEST; ARTHROSCOPIC SURGERY; ARTICLE; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOOT ARTHROPLASTY; FRACTURE; HAND SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE DISCHARGE; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS PARTICLE AGGLUTINATION; RISK ASSESSMENT; SHOULDER ARTHROPLASTY; SKIN REDNESS; SPINE SURGERY; SURGICAL INFECTION; SYNOVECTOMY; TOTAL ELBOW PROSTHESIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; WOUND DEHISCENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT; C-REACTIVE PROTEIN; DRUG THERAPY, COMBINATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS; REOPERATION; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79551694183     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2010.01579.x     Document Type: Article

References (21)

1. Doran MF, Crowson CSPond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46, 2287-93.
2. Arnett FC, Edworthy SM, Bloch DA, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
3. Steinbrocker O, Traeger CH, Battman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140, 659-62.
4. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. (2005) Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 52, 3381-90.
5. Giles JT, Bartlett SJ, Gelber JC, et al. (2006) Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopaedic infection in rheumatoid arthritis. Arthritis Rheum 55, 333-7.
6. Den Broeder AA, Creemers MC, Fransen J, et al. (2007) Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 34, 689-95.
7. Waaler E (1940) On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 117, 172-88.
8. Singer JM, Plotz CM (1956) The latex fixation test. Am J Med 21, 888-96.
9. Shmerling RH, Delbanco TL (1991) The rheumatoid factor: an analysis of clinical utility. Am J Med 91, 528-34.
10. Verstappen SMM, Hoes JN, Jacob JWG, ter Borg EJ, Bijlsma JWJ (2005) Occurrence and predictors of joint surgery in the Utrecht rheumatoid arthritis cohort [abstract]. Ann Rheum Dis 64, 216.
11. Da Silva E, Doran MF, Crowson CS, O'Fallon WM, Matteson EL (2003) Declining use of orthopaedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment. Arthritis Rheum 49, 216-20.
12. Wolfe F, Zwilich SH (1998) The long-term outcomes of rheumatoid arthritis: a 23-year prospective longitudinal study of total joint replacement and its predictors in 1600 patients with rheumatoid arthritis. Arthritis Rheum 41, 1072-82.
13. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60, 214-7.
14. Hamalainen M, Raunio P, Von Essen R (1984) Postoperative wound infection in rheumatoid arthritis surgery. Clin Rheumatol 3, 329-35.
15. Bongartz T, Halligan CS, Osmon DR, Hanssen AD, Bamlet WR, Matteson EL (2005) Incidence and risk factors for prosthetic joint infections in patients with rheumatoid arthritis following total knee and total hip replacement [abstract]. Arthritis Rheum 52(Suppl.), 1449.
16. Maini R, St ClairEW, Breedveld F, et al. (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. ATTRACT Study Group. Lancet 354, 1932-9.
17. Lipsky PE, van der Heijde DM, St Clair EW, et al. (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Eng J Med 343, 1594-602.
18. Weinblatt ME, Kremer JM, Bankhurst AD, et al. (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340, 253-9.
19. Furst DE, Schiff MH, Fleischmann RM, et al. (2003) Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 30, 2563-71.
20. Singh G, Ramey DR, Rausch PL, Schettler JD (1999) Serious infections in rheumatoid arthritis: relationship to immunosuppressive use. Arthritis Rheum 42(Suppl.), S71-474.
21. Ruyssen-Witrand A, Gossec L, Salliot C, et al. (2007) Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 25, 430-6.